These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 18482193)

  • 1. Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections.
    Pillonel J; Barin F; Laperche S; Bernillon P; Le Vu S; Brunet S; Thierry D; Desenclos JC;
    Transfusion; 2008 Aug; 48(8):1567-75. PubMed ID: 18482193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil.
    Barreto CC; Sabino EC; Gonçalez TT; Laycock ME; Pappalardo BL; Salles NA; Wright DJ; Chamone DF; Busch MP
    Transfusion; 2005 Nov; 45(11):1709-14. PubMed ID: 16271094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of HIV infection from blood transfusion in Montreal.
    Remis RS; Delage G; Palmer RW
    CMAJ; 1997 Aug; 157(4):375-82. PubMed ID: 9275944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for human immunodeficiency virus infection among blood donors in Sao Paulo, Brazil, and their relevance to current donor deferral criteria.
    de Almeida Neto C; McFarland W; Murphy EL; Chen S; Nogueira FA; Mendrone A; Salles NA; Chamone DA; Sabino EC
    Transfusion; 2007 Apr; 47(4):608-14. PubMed ID: 17381618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
    Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
    AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
    McFarland W; Mvere D; Katzenstein D
    AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors.
    Busch MP; Glynn SA; Stramer SL; Strong DM; Caglioti S; Wright DJ; Pappalardo B; Kleinman SH;
    Transfusion; 2005 Feb; 45(2):254-64. PubMed ID: 15660836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus prevalence, incidence, and residual transmission risk in first-time and repeat blood donations in Zimbabwe: implications on blood safety.
    Mapako T; Mvere DA; Chitiyo ME; Rusakaniko S; Postma MJ; van Hulst M
    Transfusion; 2013 Oct; 53(10 Pt 2):2413-21. PubMed ID: 23789991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing.
    Zou S; Dorsey KA; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY; Stramer SL
    Transfusion; 2010 Jul; 50(7):1495-504. PubMed ID: 20345570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
    Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
    Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus test-seeking motivation in blood donors, São Paulo, Brazil.
    Goncalez TT; Sabino EC; Murphy EL; Chen S; Chamone DA; McFarland W
    Vox Sang; 2006 Apr; 90(3):170-6. PubMed ID: 16507016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations.
    Benjamin RJ; Busch MP; Fang CT; Notari EP; Puren A; Schoub BD; Tobler LH; Hogrefe W; du P Heyns A; Stramer SL; Crookes RL
    Transfusion; 2008 Feb; 48(2):295-303. PubMed ID: 18005322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for estimating incidence rate of infectious diseases among first-time blood donors.
    Zou S; Fang CT; Dodd RY
    Transfusion; 2008 Sep; 48(9):1827-32. PubMed ID: 18482184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A retrospective study of the practice of "look-back" procedures, on the incidence of HIV-1/2-positive blood donors and the risk of transfusion-associated HIV infection in public-community blood banks in Germany].
    Zeiler T; Kretschmer V; Sibrowski W
    Infusionsther Transfusionsmed; 1994 Dec; 21(6):362-7. PubMed ID: 7873914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual infectious disease risk in screened blood transfusion from a high-prevalence population: Santa Catarina, Brazil.
    Maresch C; Schluter PJ; Wilson AD; Sleigh A
    Transfusion; 2008 Feb; 48(2):273-81. PubMed ID: 18005323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence and incidence of HIV and hepatitis B among blood donors and estimated residual risk of transmission of HIV and HBV virus by blood transfusion. A study at the Provincial General Referee Hospital Bukavu, Democratic Republic of the Congo].
    Namululi BA; Guerrieri C; Dramaix MW
    Rev Epidemiol Sante Publique; 2013 Apr; 61(2):139-44. PubMed ID: 23498094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.